TXLNA — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to TXLNA by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK	PHASE3	COMPLETED
Biologic Correlative Taxotere/AC	PHASE2	COMPLETED
Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer	PHASE1/PHASE2	COMPLETED
EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients	PHASE2	COMPLETED
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma	PHASE2	COMPLETED
Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients	PHASE2	COMPLETED
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension	PHASE2	COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors	PHASE1	COMPLETED
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors	PHASE1	COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors	PHASE1	COMPLETED
Tranexamic Acid Effect in Pediatric	EARLY_PHASE1	UNKNOWN
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis	EARLY_PHASE1	UNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism	nan	UNKNOWN
S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304	nan	COMPLETED
Genomic Research in Alpha-1 Antitrypsin Deficiency	nan	COMPLETED
Study of Constitutional Platelet Disease	nan	UNKNOWN
TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects	nan	COMPLETED
Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome	nan	ACTIVE_NOT_RECRUITING
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy	nan	UNKNOWN
Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations	nan	COMPLETED
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm	nan	COMPLETED
Hs-cTn - Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women	nan	ACTIVE_NOT_RECRUITING
Telomeres Length in Israeli Fibrotic ILD Patients	nan	ENROLLING_BY_INVITATION
Genome-wide Epistasis for Cardiovascular Severity in Marfan Study	nan	UNKNOWN
Pathogenetic Basis of Aortopathy and Aortic Valve Disease	nan	ACTIVE_NOT_RECRUITING
Identification of Biomarkers for Early Detection of Pancreatic Cancer	nan	COMPLETED
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals	nan	COMPLETED
Alpha-1 Carrier Genomics Study	nan	COMPLETED
CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity	nan	UNKNOWN
Role of Circulating MicroRNAs in Pathogenesis of Aneurysms of the Abdominal and Thoracic Aorta - Study Micro AAA	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a TXLNA binder may also engage these)

Protein	Name	Similarity
Q6PAM1	—	1.000	Q6PAM1 →
Q9NUQ3	—	0.990	Q9NUQ3 →
Q8BHN1	—	0.986	Q8BHN1 →
Q8CJB9	—	0.981	Q8CJB9 →
Q62036	—	0.979	Q62036 →
O75150	—	0.979	O75150 →
Q3U319	—	0.979	Q3U319 →
Q6ZUS6	—	0.978	Q6ZUS6 →
Q8IYY4	—	0.977	Q8IYY4 →
Q8VBT1	—	0.977	Q8VBT1 →
P97817	—	0.977	P97817 →
D3YV10	—	0.976	D3YV10 →
Q9UPN4	—	0.976	Q9UPN4 →
GOLGA2	Golgin subfamily A member 2	0.976	landscape →
Q96G01	—	0.975	Q96G01 →
Q4R7K7	—	0.975	Q4R7K7 →
Q5RAU7	—	0.974	Q5RAU7 →
Q17QG3	—	0.974	Q17QG3 →
Q921M4	—	0.974	Q921M4 →
Q9JHZ4	—	0.974	Q9JHZ4 →
Q4V328	—	0.973	Q4V328 →
Q5XJA2	—	0.973	Q5XJA2 →
Q8N3L3	—	0.972	Q8N3L3 →
Q569K6	—	0.972	Q569K6 →
Q5ZLS3	—	0.972	Q5ZLS3 →
A2A9T0	—	0.972	A2A9T0 →
Q86X02	—	0.972	Q86X02 →
B1H222	—	0.972	B1H222 →
Q6NRH3	—	0.972	Q6NRH3 →
Q8IYE1	—	0.971	Q8IYE1 →